Itch intensity in prurigo nodularis is closely related to dermal interleukin‐31, oncostatin M, IL‐31 receptor alpha and oncostatin M receptor beta

2021 ◽  
Author(s):  
Takashi Hashimoto ◽  
Leigh A. Nattkemper ◽  
Hei Sung Kim ◽  
Christina D. Kursewicz ◽  
Emilie Fowler ◽  
...  
2019 ◽  
Vol 139 (5) ◽  
pp. S35
Author(s):  
Z. Mikhak ◽  
S. Ständer ◽  
D. Metze ◽  
G. Yosipovitch ◽  
J. Silverberg ◽  
...  

2019 ◽  
Vol 139 (5) ◽  
pp. S96 ◽  
Author(s):  
Z. Mikhak ◽  
R. Bissonnette ◽  
D. Siri ◽  
S.K. Tyring ◽  
E. Tessari ◽  
...  

2011 ◽  
Vol 34 (3) ◽  
pp. 177-187 ◽  
Author(s):  
Tasneem Kausar ◽  
Rinu Sharma ◽  
Md. Raghibul Hasan ◽  
Anoop Saraya ◽  
Tushar K. Chattopadhyay ◽  
...  

2021 ◽  
Vol 10 (9) ◽  
pp. 1906
Author(s):  
Masutaka Furue ◽  
Mihoko Furue

Skin inflammation often evokes pruritus, which is the major subjective symptom in many inflammatory skin diseases such as atopic dermatitis and prurigo nodularis. Pruritus or itch is a specific sensation found only in the skin. Recent studies have stressed the pivotal role played by interleukin-31 (IL-31) in the sensation of pruritus. IL-31 is produced by various cells including T helper 2 cells, macrophages, dendritic cells and eosinophils. IL-31 signals via a heterodimeric receptor composed of IL-31 receptor A (IL-31RA) and oncostatin M receptor β. Recent clinical trials have shown that the anti-IL-31RA antibody nemolizumab can successfully decrease pruritus in patients with atopic dermatitis and prurigo nodularis. The IL-31 pathway and pruritic skin are highlighted in this review article.


2021 ◽  
Vol 22 (8) ◽  
pp. 3831
Author(s):  
Tiziana Bachetti ◽  
Francesca Rosamilia ◽  
Martina Bartolucci ◽  
Giuseppe Santamaria ◽  
Manuela Mosconi ◽  
...  

Hirschsprung (HSCR) Associated Enterocolitis (HAEC) is a common life-threatening complication in HSCR. HAEC is suggested to be due to a loss of gut homeostasis caused by impairment of immune system, barrier defense, and microbiome, likely related to genetic causes. No gene has been claimed to contribute to HAEC occurrence, yet. Genetic investigation of HAEC by Whole-Exome Sequencing (WES) on 24 HSCR patients affected (HAEC) or not affected (HSCR-only) by enterocolitis and replication of results on a larger panel of patients allowed the identification of the HAEC susceptibility variant p.H187Q in the Oncostatin-M receptor (OSMR) gene (14.6% in HAEC and 5.1% in HSCR-only, p = 0.0024). Proteomic analysis on the lymphoblastoid cell lines from one HAEC patient homozygote for this variant and one HAEC patient not carrying the variant revealed two well distinct clusters of proteins significantly up or downregulated upon OSM stimulation. A marked enrichment in immune response pathways (q < 0.0001) was shown in the HAEC H187 cell line, while proteins upregulated in the HAEC Q187 lymphoblasts sustained pathways likely involved in pathogen infection and inflammation. In conclusion, OSMR p.H187Q is an HAEC susceptibility variant and perturbates the downstream signaling cascade necessary for the gut immune response and homeostasis maintenance.


2015 ◽  
Vol 34 (4) ◽  
pp. S174
Author(s):  
M.H. Richter ◽  
H. Lautze ◽  
W. Skwara ◽  
M. Schönburg ◽  
A. Beiras-Fernandez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document